1. Hot-melt co-extrusion technology as a manufacturing platform for anti-hypertensive fixed-dose combinations
- Author
-
Shu Li, Zoe Senta-Loys, Anne Marie Healy, Gareth C. Gilvary, Ammar Almajaan, Yiwei Tian, David S. Jones, Gavin Andrews, and Jeremiah Kelleher
- Subjects
Losartan Potassium ,Materials science ,Mechanical Engineering ,Energy Engineering and Power Technology ,Core (manufacturing) ,Management Science and Operations Research ,Fixed dose ,Dosage form ,Co extrusion ,Hydrochlorothiazide ,Chemical engineering ,medicine ,Hot melt ,medicine.drug - Abstract
This work focused on the development of a concentric multi-layered fixed-dose combination via an advanced manufacturing technique, hot-melt co-extrusion. The dosage form was designed to offer differing release behaviour; immediate and sustained release from the coat and core, respectively. Hydrochlorothiazide and losartan potassium were incorporated as anti-hypertensive drugs. Solid-state characterisation revealed that both were transformed into their amorphous forms. In-vitro dissolution testing showed desired release performances offering both immediate and modified release.
- Published
- 2019
- Full Text
- View/download PDF